Orthopediatrics (KIDS) Cash & Equivalents (2015 - 2026)

Orthopediatrics has reported Cash & Equivalents for 12 years, with the latest figure at $12.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 63.54% year-over-year to $12.2 million; the trailing twelve-month figure through Mar 2026 stood at $12.2 million (down 63.54% YoY), and the FY2025 full-year result was $19.6 million, down 55.37% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $12.2 million, down from $19.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $51.0 million in Q3 2024, with the low at $9.0 million in Q4 2022.
• Average Cash & Equivalents over 5 years is $26.4 million, with a median of $25.3 million recorded in 2024.
• Year-over-year, Cash & Equivalents sank 73.89% in 2023 and jumped 379.77% in 2024.
• Tracing KIDS's Cash & Equivalents over 5 years: stood at $9.0 million in 2022, then soared by 245.4% to $31.1 million in 2023, then surged by 41.1% to $43.8 million in 2024, then slumped by 55.37% to $19.6 million in 2025, then slumped by 37.65% to $12.2 million in 2026.
• The last three Cash & Equivalents figures came in at $12.2 million (Q1 2026), $19.6 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.

Peer Comparison